Cerenis Therapeutics

HDL breakthroughs to patients

Cerenis Therapeutics is a multinational biopharmaceutical company, dedicated to the discovery and development of novel HDL therapies for the treatment of cardiovascular and metabolic diseases.

Cerenis aims to become the leader in the HDL therapeutic market with a broad portfolio of programs in development.